162 related articles for article (PubMed ID: 35496311)
1. Mogrol Attenuates Osteoclast Formation and Bone Resorption by Inhibiting the TRAF6/MAPK/NF-κB Signaling Pathway
Chen Y; Zhang L; Li Z; Wu Z; Lin X; Li N; Shen R; Wei G; Yu N; Gong F; Rui G; Xu R; Ji G
Front Pharmacol; 2022; 13():803880. PubMed ID: 35496311
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
3. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
4. Rosavin suppresses osteoclastogenesis
Zhang W; Zhang W; Huo L; Chai Y; Liu Z; Ren Z; Yu C
Ann Transl Med; 2021 Mar; 9(5):383. PubMed ID: 33842604
[TBL] [Abstract][Full Text] [Related]
5. TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid.
Tan EM; Li L; Indran IR; Chew N; Yong EL
J Bone Miner Res; 2017 Apr; 32(4):846-860. PubMed ID: 27813153
[TBL] [Abstract][Full Text] [Related]
6. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways.
Xiao L; Zhong M; Huang Y; Zhu J; Tang W; Li D; Shi J; Lu A; Yang H; Geng D; Li H; Wang Z
Aging (Albany NY); 2020 Nov; 12(21):21706-21729. PubMed ID: 33176281
[TBL] [Abstract][Full Text] [Related]
7. Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.
Li X; Wang Y; Li L; Zhou S; Zhao F
Cell Biol Toxicol; 2021 Dec; 37(6):849-871. PubMed ID: 33423118
[TBL] [Abstract][Full Text] [Related]
8. Ellagic acid protects ovariectomy-induced bone loss in mice by inhibiting osteoclast differentiation and bone resorption.
Lin X; Yuan G; Li Z; Zhou M; Hu X; Song F; Shao S; Fu F; Zhao J; Xu J; Liu Q; Feng H
J Cell Physiol; 2020 Sep; 235(9):5951-5961. PubMed ID: 32026468
[TBL] [Abstract][Full Text] [Related]
9. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
10. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
11. Gamabufotalin Inhibits Osteoclastgenesis and Counteracts Estrogen-Deficient Bone Loss in Mice by Suppressing RANKL-Induced NF-κB and ERK/MAPK Pathways.
Sun K; Zhu J; Deng Y; Xu X; Kong F; Sun X; Huan L; Ren C; Sun J; Shi J
Front Pharmacol; 2021; 12():629968. PubMed ID: 33967763
[TBL] [Abstract][Full Text] [Related]
12. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway.
Qiu Z; Li L; Huang Y; Shi K; Zhang L; Huang C; Liang J; Zeng Q; Wang J; He X; Qin L; Wang X
J Orthop Translat; 2022 Mar; 33():55-69. PubMed ID: 35228997
[TBL] [Abstract][Full Text] [Related]
13. Guaiacol suppresses osteoclastogenesis by blocking interactions of RANK with TRAF6 and C-Src and inhibiting NF-κB, MAPK and AKT pathways.
Zhi X; Fang C; Gu Y; Chen H; Chen X; Cui J; Hu Y; Weng W; Zhou Q; Wang Y; Wang Y; Jiang H; Li X; Cao L; Chen X; Su J
J Cell Mol Med; 2020 May; 24(9):5122-5134. PubMed ID: 32185887
[TBL] [Abstract][Full Text] [Related]
14. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
[TBL] [Abstract][Full Text] [Related]
15. Asiatic Acid Attenuates Osteoporotic Bone Loss in Ovariectomized Mice Through Inhibiting NF-kappaB/MAPK/ Protein Kinase B Signaling Pathway.
Dong M; Zeng J; Yang C; Qiu Y; Wang X
Front Pharmacol; 2022; 13():829741. PubMed ID: 35211021
[TBL] [Abstract][Full Text] [Related]
16. Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.
Guo Q; Cao Z; Wu B; Chen F; Tickner J; Wang Z; Qiu H; Wang C; Chen K; Tan R; Gao Q; Xu J
J Cell Physiol; 2018 Jan; 234(1):789-801. PubMed ID: 30078210
[TBL] [Abstract][Full Text] [Related]
17. MiR-143 Inhibits Osteoclastogenesis by Targeting RANK and NF-κB and MAPK Signaling Pathways.
He X; Zhu L; An L; Zhang J
Curr Mol Pharmacol; 2020; 13(3):224-232. PubMed ID: 31951177
[TBL] [Abstract][Full Text] [Related]
18. Tereticornate A suppresses RANKL-induced osteoclastogenesis via the downregulation of c-Src and TRAF6 and the inhibition of RANK signaling pathways.
Liu T; Jiang L; Xiang Z; Li J; Zhang Y; Xiang T; Wang W; Li X; Jia Y; Huang X; Lu X; Xu H; Wang X; Sheng J
Biomed Pharmacother; 2022 Jul; 151():113140. PubMed ID: 35605290
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2.
Li Z; Chen C; Zhu X; Li Y; Yu R; Xu W
Calcif Tissue Int; 2018 Sep; 103(3):324-337. PubMed ID: 29721581
[TBL] [Abstract][Full Text] [Related]
20. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]